Stanley C. Erck

2015

In 2015, Stanley C. Erck earned a total compensation of $4.9M as President, CEO and Interim CFO at Novavax, a 57% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$345,000
Option Awards$3,924,000
Salary$575,000
Other$7,800
Total$4,851,800

Erck received $3.9M in option awards, accounting for 81% of the total pay in 2015.

Erck also received $345K in non-equity incentive plan, $575K in salary and $7.8K in other compensation.

Rankings

In 2015, Stanley C. Erck's compensation ranked 1,667th out of 13,638 executives tracked by ExecPay. In other words, Erck earned more than 87.8% of executives.

ClassificationRankingPercentile
All
1,667
out of 13,638
88th
Division
Manufacturing
603
out of 5,187
88th
Major group
Chemicals And Allied Products
219
out of 1,857
88th
Industry group
Drugs
169
out of 1,531
89th
Industry
Biological Products, Except Diagnostic Substances
29
out of 260
89th
Source: SEC filing on April 30, 2018.

Erck's colleagues

We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2015.

2015

Gregory Glenn

Novavax

President, Research and Development

2015

Barclay Phillips

Novavax

Chief Financial Officer

2015

John Trizzino

Novavax

SVP, Commercial Operations

2015

John Herrmann

Novavax

General Counsel

News

In-depth

You may also like